泌尿支架市场：规模、细分市场、份额、法规、报销、程序、到 2033 年的预测

泌尿支架是插入泌尿道或输尿管的聚合物或金属管状装置，用于治疗或预防阻止尿液从肾臟流向膀胱的阻塞。 输尿管支架是一种专门设计的 10 至 12 英吋长的软管，放置在输尿管中，将尿液从肾臟引流到膀胱。

摄护腺癌、良性摄护腺增生症（BPH）、尿石症、肾结石等的盛行率逐年上升。 预计这将在预测期内推动泌尿支架置入术的需求。 越来越多的人面临正常排尿困难，这是泌尿支架置放术需求逐年增加的主要原因之一。

本报告深入探讨了全球泌尿道支架市场，包括竞争格局、SWOT 分析、至 2033 年的市场预测、COVID-19 的影响、区域和国家趋势等。我是。

目录

尿路支架目前市场及竞争状况

• 对主要产业趋势的见解
• 2015年至2033年按细分市场划分的尿路支架市场总收入及市场前景
• 有关数量、平均售价和市场价值的详细数据

全球、区域与国家见解

• 泌尿支架市场SWOT分析
• 泌尿支架市场的竞争动态洞察与趋势
• 各国医疗保健系统概览
• 按国家/地区划分的报销政策
• 各国医疗科技的监管状况

Abstract

Urinary Tract Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Nephrology and Urology Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Urinary Tract Stents market for the year 2020 and beyond. Urinary tract stents are the tubular devices made either of polymers and metal which are inserted into the urinary tract or ureter to treat or prevent a blockage that prevents the flow of urine from the kidney to the bladder. A ureteral stent is specially designed a soft tube 10-12 inches in length that is placed in the ureter for draining urine from the kidney to the urinary bladder.

The increasing prevalence of prostate cancer, Benign Prostatic Hyperplasia (BPH), Urolithiasis and stone among people in the kidney has seen a staggering rise over the years. This is anticipated to propel the demand for urinary tract stenting over the forecast periods. The developing number of individuals facing difficulties in passing urine normally is one of the key reasons why the demand for urinary tract stenting is increasing throughout the years.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Urinary Tract Stents and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Urinary Tract Stents market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Urinary Tract Stents market.
• Competitive dynamics insights and trends provided for Urinary Tract Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Cook Group Inc, Becton Dickinson and Co, Olympus Corp, Coloplast A/S, Applied Medical Corporation, Allium Medical Solutions Ltd, Pnn Medical A/S, SRS Medical Systems Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

• CMO executives who must have deep understanding of the Urinary Tract Stents marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

• Understand the impact of COVID-19 on Urinary Tract Stents market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Urinary Tract Stents market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Urinary Tract Stents market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Urinary Tract Stents market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.